Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 1
2018 2
2019 2
2021 3
2022 2
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

11 results

Results by year

Filters applied: . Clear all
Page 1
Cationic-nanogel nasal vaccine containing the ectodomain of RSV-small hydrophobic protein induces protective immunity in rodents.
Umemoto S, Nakahashi-Ouchida R, Yuki Y, Kurokawa S, Machita T, Uchida Y, Mori H, Yamanoue T, Shibata T, Sawada SI, Ishige K, Hirano T, Fujihashi K, Akiyoshi K, Kurashima Y, Tokuhara D, Ernst PB, Suzuki M, Kiyono H. Umemoto S, et al. Among authors: uchida y. NPJ Vaccines. 2023 Jul 24;8(1):106. doi: 10.1038/s41541-023-00700-3. NPJ Vaccines. 2023. PMID: 37488116 Free PMC article.
Biodistribution assessment of cationic pullulan nanogel, a nasal vaccine delivery system, in mice and non-human primates.
Yuki Y, Harada N, Sawada SI, Uchida Y, Nakahashi-Ouchida R, Mori H, Yamanoue T, Machita T, Kanazawa M, Fukumoto D, Ohba H, Miyazaki T, Akiyoshi K, Fujihashi K, Kiyono H. Yuki Y, et al. Among authors: uchida y. Vaccine. 2023 Jul 31;41(34):4941-4949. doi: 10.1016/j.vaccine.2023.06.065. Epub 2023 Jun 27. Vaccine. 2023. PMID: 37385890 Free article.
A nanogel-based trivalent PspA nasal vaccine protects macaques from intratracheal challenge with pneumococci.
Nakahashi-Ouchida R, Uchida Y, Yuki Y, Katakai Y, Yamanoue T, Ogawa H, Munesue Y, Nakano N, Hanari K, Miyazaki T, Saito Y, Umemoto S, Sawada SI, Mukerji R, Briles DE, Yasutomi Y, Akiyoshi K, Kiyono H. Nakahashi-Ouchida R, et al. Among authors: uchida y. Vaccine. 2021 Jun 8;39(25):3353-3364. doi: 10.1016/j.vaccine.2021.04.069. Epub 2021 May 17. Vaccine. 2021. PMID: 34016473 Free article.
Induction of Mucosal IgA-Mediated Protective Immunity Against Nontypeable Haemophilus influenzae Infection by a Cationic Nanogel-Based P6 Nasal Vaccine.
Nakahashi-Ouchida R, Mori H, Yuki Y, Umemoto S, Hirano T, Uchida Y, Machita T, Yamanoue T, Sawada SI, Suzuki M, Fujihashi K, Akiyoshi K, Kurono Y, Kiyono H. Nakahashi-Ouchida R, et al. Among authors: uchida y. Front Immunol. 2022 Jul 6;13:819859. doi: 10.3389/fimmu.2022.819859. eCollection 2022. Front Immunol. 2022. PMID: 35874779 Free PMC article.
Characterization and Specification of a Trivalent Protein-Based Pneumococcal Vaccine Formulation Using an Adjuvant-Free Nanogel Nasal Delivery System.
Yuki Y, Uchida Y, Sawada SI, Nakahashi-Ouchida R, Sugiura K, Mori H, Yamanoue T, Machita T, Honma A, Kurokawa S, Mukerji R, Briles DE, Akiyoshi K, Kiyono H. Yuki Y, et al. Among authors: uchida y. Mol Pharm. 2021 Apr 5;18(4):1582-1592. doi: 10.1021/acs.molpharmaceut.0c01003. Epub 2021 Feb 23. Mol Pharm. 2021. PMID: 33621107 Free article.
A role for the CCR5-CCL5 interaction in the preferential migration of HSV-2-specific effector cells to the vaginal mucosa upon nasal immunization.
Joo S, Suwanto A, Sato A, Nakahashi-Ouchida R, Mori H, Uchida Y, Sato S, Kurashima Y, Yuki Y, Fujihashi K, Kawaguchi Y, Kiyono H. Joo S, et al. Among authors: uchida y. Mucosal Immunol. 2019 Nov;12(6):1391-1403. doi: 10.1038/s41385-019-0203-z. Epub 2019 Sep 24. Mucosal Immunol. 2019. PMID: 31551493 Free article.
Oral MucoRice-CTB vaccine for safety and microbiota-dependent immunogenicity in humans: a phase 1 randomised trial.
Yuki Y, Nojima M, Hosono O, Tanaka H, Kimura Y, Satoh T, Imoto S, Uematsu S, Kurokawa S, Kashima K, Mejima M, Nakahashi-Ouchida R, Uchida Y, Marui T, Yoshikawa N, Nagamura F, Fujihashi K, Kiyono H. Yuki Y, et al. Among authors: uchida y. Lancet Microbe. 2021 Sep;2(9):e429-e440. doi: 10.1016/S2666-5247(20)30196-8. Epub 2021 Jun 25. Lancet Microbe. 2021. PMID: 35544149 Free article. Clinical Trial.
11 results